ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687527 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687527; 2) Community: the network communities that were significantly associated with the response to NSC 687527; 3) Molecule: the relationships between components within communities and NSC 687527; 4) MDR: the compounds that were significantly associated with the NSC 687527.

NSC Compound Enrichment Correlation
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0434721470609156 0.51374185
NSC 753598 Null 0.0434721470609156 0.12384727
NSC 756375 GW811761X 0.0434721470609156 0.026768631
NSC 756483 SB-742864 0.0434721470609156 0.50688896
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0434721470609156 0.3962289
NSC 762346 Null 0.0434721470609156 0.29768668
NSC 93819 Depakine 0.0434721470609156 0.026613809
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.0446159312763229 0.42376852
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0446159312763229 0.3045493
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0446159312763229 -0.018583565
Total:80  Current:63    [First] [Prev] [Next] [Last]